Pancreatic cancer organoid-screening captures personalized sensitivity and chemoresistance suppression upon cytochrome P450 3A5-targeted inhibition

Meritxell B. Cutrona,1,4,*Jing Wu,1Ka Yang,2Junmin Peng,2,3and Taosheng Chen
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks
1Department of Chemical Biology and Therapeutics, St. Jude Children’s Research Hospital, Memphis, TN 38105-3678, USA2Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105-3678, USA3Department of Developmental Neurobiology, St. Jude Children’s Research Hospital, Memphis, TN 38105-3678, USA
4 Lead Contact*Correspondence:meritxell.baocutrona@stjude.org(M.B.C.),taosheng.chen@stjude.org(T.C.)https://doi.org/10.1016/j.isci.2024.110289iScience27, 110289, July 19, 2024ª2024 The Author(s). Published by Elsevier Inc.This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1llOPENACCESS

Please sign in or register for FREE

If you are a registered user on WORC.Community, please sign in